β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value

OBJECTIVE: β-lactams are the cornerstone of empiric and targeted antibiotic therapy for critically ill patients. Recently, there have been calls to use β-lactam therapeutic drug monitoring (TDM) within 24–48 hours after the initiation of therapy in critically ill patients. In this article, we review...

Descripción completa

Detalles Bibliográficos
Autores principales: Dilworth, Thomas J., Schulz, Lucas T., Micek, Scott T., Kollef, Marin H., Rose, Warren E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259115/
https://www.ncbi.nlm.nih.gov/pubmed/35815181
http://dx.doi.org/10.1097/CCE.0000000000000726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259115/
https://www.ncbi.nlm.nih.gov/pubmed/35815181
http://dx.doi.org/10.1097/CCE.0000000000000726

Ejemplares similares